Skip to main content

Table 3 Health care reforms since 1988. (Sources: Carrera et al. (2008); ASISP (2012))

From: The politics of incremental change: institutional change in old-age pensions and health care in GermanyDie Politik der schrittweisen Veränderung: Institutioneller Wandel bei Altersrenten und Gesundheitsversorgung in Deutschland

Year enacted

Reform

Parties in government

Government majority in Bundesrat?

Consent Bundesrat required?

Both SPD & CDU/CSU support reform?

Reform content

1988

Health Care Reform Law

(Gesundheitsreformgesetz)

CDU/CSU & FDP

Yes

Yes

No

Introduction/increase of co-payments for medical supplies, drugs, dental care, and inpatient care

Fewer insured drugs

1992

Health Care Structure Reform Act (Gesundheitsstrukturgesetz)

CDU/CSU & FDP

No

Yes

Yes

Higher co-payments and user fees

Mixed-payment system

Budget cap for doctors

Supply of doctors limited

Reference pricing

1996

Health Insurance Contribution Exoneration Act (Beitragsentlastungsgesetz)

CDU/CSU & FDP

No

Yes

SPD states in Bundesrat agree to law

Co-payments for prescriptions

Modest fee for initial ambulatory treatment

Higher co-payment for inpatient care

Lower benefits for spa treatment

Over-the-counter medications no longer insured

1997

Second SHI Restructuring Act (2. GKV-Neuordnungsgesetz)

CDU/CSU & FDP

No

No

No

Budget caps for doctors & dentists

Morbidity-based compensation for ambulatory doctors

1998

Act to Strengthen Solidarity in SHI (GKV-Solidaritätsstärkungsgesetz)

SDP & Greens

Yes

Yes

No

Softening of impact of higher co-payments

Additional reference pricing for medicines

Mandatory price cuts for medicines

Rebate sysmtem for drug manufacturers and wholesalers

1999

SHI Reform Act (GKV-Reform 2000)

SPD & Greens

No

No

No

Diagnosis related group (DRG) payment

Risk structure compensation

2001

Reference Price Adjustment Act (Festbetragsanpassungsgesetz)

SPD & Greens

No

Yes

Some CDU states in Bundesrat support legislation

Shift to reference pricing

Ministerial control of medical pricing

2001

Pharmaceutical Budget Abolition Act (Arzneimittelbudget-Ablösungsgesetz)

SPD & Greens

No

Yes

Some CDU states in Bundesrat support legislation

Additional budget caps for doctors

2002

Pharmaceutical Expenditure Limitation Act (Arzneimittelausgaben-Begrenzungsgesetz)

SPD & Greens

No

Yes

Some CDU states in Bundesrat support legislation

Physicians’ budget cap

Mandatory use of generic drugs

2002

Case Fees Act (Festbetrags-Anpassungsgesetz)

SPD & Greens

No

Yes

Some CDU states in Bundesrat support legislation

DRG payments

2002

Contribution Rate Stabilization Act (Beitragssatzsicherungsgesetz)

SPD & Greens

No

No

No

Reference pricing

2002

DRG Law for Hospitals

(Gesetz zur Einführung des diagnose-orientierten Fallpauschalensystems für Krankenhäuser) (Fallpauschalengesetz-FPG)

SPD & Greens

No

Yes

Some CDU states in Bundesrat support legislation

DRG Payment

2003

SHI Modernization Act

(GKV-Modernisierungsgesetz)

SDP & Greens

No

Yes

CDU/CSU support at early stage

Co-payments and user fees

Modest reduction in benefits

Reference pricing

Reimbursement of out-patient care in EU

Risk-structure compensation

Increase in use of health technology assessments

2007

Law to strengthen competition between SHIs (GKV-Wettbewerbsstärkungsgesetz GKV-WSG)

SDP & CDU/CSU

Yes

Yes

Yes

Pooling of SHI contributions in a central “Health Fund” (Gesundheitsfonds)

Uniform contribution rates across SHI funds; supplementary premiums for funds with insufficient revenue from the central fund

Insurance mandatory for all

2010

Law on the Change of the SHI

(GKV-Änderungsgesetz GKV-ÄndG)

CDU/CSU & FDP

Yes

No

No

Obligatory discounts on drugs,and price freeze until 2013

Employer SHI contribution share frozen at 7.3 %

2011

Law on Financing the SHI (GKV-Finanzierungsgesetz GKV-FinG)

CDU/CSU & FDP

No

No

No

Contributions to SFs increased (from 14.9 to 15.4 % in 2011)

Employers’ share of contributions frozen at 7.3 % of qualifying income

Compensation for low-income households

Modest reduction in cost indexation for hospitals

2011

Law on the Re-organisation of the Market for Pharmaceuticals (Gesetz zur Neuordnung des Arzneimittelmarktes AMNOG)

CDU/CSU & FDP

No

No

No

Modified reference pricing for new drugs

2012

Law on Health Care Structure (GKV-Versorgungsstrukturgesetz GKV-VStG)

CDU/CSU & FDP

No

No

No

Adjustment in policies affecting supply of doctors

Increase in ways that SFs can differentiate their services